Delivery Order SPE2DB22D9112-SPE2DB24FE6VW

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,317.08, is for the delivery of PREVNAR 20 syringes (0.5 mL) to support the medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,722.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product, with a period of performance through July 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the...
This is a $3,544.74 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Prevnar 20 syringe 0.5 ML to support the recurring medical supply needs of military health facilities. It is associated with a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a $9,263.00 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of PREVNAR 20 syringes, a vaccine product, to support the medical supply needs of military health facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $5,765.69, is for the delivery of PREVNAR 20 syringes (0.5 mL) to support the medical supply needs of U.S. military health facilities. The contract has a period of performance through April 8, 2024 and is a firm fixed-price delivery order under DMS Pharmaceutical Group's existing indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,772.36, is for the delivery of PREVNAR 20 vaccine syringes (0.5 mL) to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,544.44 contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of July 10, 2024 and is not associated with any set-aside designation....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $177,236.00 order is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with a period of performance through July 10, 2024. The award is issued against a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $26,585.40, is for the delivery of PREVNAR 20 syringes (0.5 ml) to support the medical supply needs of the U.S. Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,447.20, is for the delivery of Prevnar 20 syringes. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FE6VW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,089.44, is for the delivery of PREVNAR 20 SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This order is issued under a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA. The IDC, which runs through December 31, 2025, allows the DLA to place delivery orders for a comprehensive range of pharmaceutical items, including both common and specialized products, to fulfill the diverse medical requirements of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities. The contract has no set-aside designation.

Generated 10/9/24, 9:11 AM